Evaluation of pH-sensitive fusogenic polymer-modified liposomes co-loaded with antigen and α-galactosylceramide as an anti-tumor vaccine-Reference-Cited by-同舟云学术

Evaluation of pH-sensitive fusogenic polymer-modified liposomes co-loaded with antigen and α-galactosylceramide as an anti-tumor vaccine

Published:2018 Issue:2 Volume:80 Page:197-204
ISSN:0916-7250
Container-title:Journal of Veterinary Medical Science
language:en
Short-container-title:The Journal of Veterinary Medical Science

Author:

OKAZAKI Seiji¹,IWASAKI Tadashi¹,YUBA Eiji²,WATARAI Shinobu¹

Affiliation:

1. Division of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Osaka 598-8531, Japan

2. Department of Applied Chemistry, Graduate School of Engineering, Osaka Prefecture University, Sakai, Osaka 599-8531, Japan

Publisher

Japanese Society of Veterinary Science

Subject

General Veterinary

Link

https://www.jstage.jst.go.jp/article/jvms/80/2/80_17-0491/_pdf

Reference31 articles.

1. 1. Buckanovich, R. J., Facciabene, A., Kim, S., Benencia, F., Sasaroli, D., Balint, K., Katsaros, D., O’Brien-Jenkins, A., Gimotty, P. A. and Coukos, G. 2008. Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat. Med. 14: 28–36.

2. 2. Bülow, R. and Boothroyd, J. C. 1991. Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. J. Immunol. 147: 3496–3500.

3. 3. Dudek, A. M., Martin, S., Garg, A. D. and Agostinis, P. 2013. Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front. Immunol. 4: 438.

4. 4. Fujii, S., Liu, K., Smith, C., Bonito, A. J. and Steinman, R. M. 2004. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199: 1607–1618.

5. 5. Fujii, S., Shimizu, K., Okamoto, Y., Kunii, N., Nakayama, T., Motohashi, S. and Taniguchi, M. 2013. NKT cells as an ideal anti-tumor immunotherapeutic. Front. Immunol. 4: 409.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancement of intranasal mucosal immunization of mucosal vaccines by ultrasonic treatment;Bio-Design and Manufacturing;2023-03-24

2. Phospholipid-Membrane-Based Nanovesicles Acting as Vaccines for Tumor Immunotherapy: Classification, Mechanisms and Applications;Pharmaceutics;2022-11-11

3. Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches;Journal of Controlled Release;2022-11

4. Cationic lipid potentiated the adjuvanticity of polysaccharide derivative-modified liposome vaccines;Journal of Controlled Release;2022-10

5. A comprehensive review on different approaches for tumor targeting using nanocarriers and recent developments with special focus on multifunctional approaches;Journal of Pharmaceutical Investigation;2022-07-28